Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 72 hours of start of study treatment
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 7 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within 2 weeks of study entry
Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within 72 hours of study entry
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 7 days of the start of treatment
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant or breastfeeding; a negative serum pregnancy test is required no more than 14 days before study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative urine pregnancy test within 7 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have two negative pregnancy tests; the first test should be performed within 10-14 days of study entry, and the second test within 24 hours prior to prescribing pomalidomide
Pregnant women, or women of childbearing potential without a negative pregnancy test (serum or urine) within 7 days prior to randomization, irrespective of the method of contraception used, are excluded from this study; breastfeeding must be discontinued prior to study entry
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 3 days of signing consent
Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum or urine pregnancy test within 7 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum or urine pregnancy test within 7 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 72 hours of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within 72 hours of study entry
Pregnant or nursing; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 7 days of study entry
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within 14 days of study entry.
Pregnant or breastfeeding; a negative serum pregnancy test is required no more than 7 days before study entry
Pregnant and/or breastfeeding; premenopausal women must have a negative serum or urine pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; premenopausal women must have a negative serum or urine pregnancy test within 14 days of study entry (Arm B)
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 7 days of start of study treatment
Pregnant or breastfeeding; a negative serum pregnancy test is required no more than 7 days before study entry
Pregnant and/or breastfeeding; patients of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within 7 days of study entry if premenopausal
Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within 24 hours of study entry
Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within 14 days of study entry and again within 24 hours prior to first treatment.
Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within 7 days of first dose of vaccine.
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Female patients who are pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within 14 days of study entry
Pregnant or breastfeeding, or intending to become pregnant during the study; women of childbearing potential must have a negative serum pregnancy test result within 14 days prior to initiation of study treatment
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 7 days of first dose of vaccine
Pregnant and/or breastfeeding; patient must have a negative urine pregnancy test within 14 days of study entry
Women of reproductive potential must not be pregnant or breastfeeding and have a negative urine or serum pregnancy test obtained within 7 days prior to the first dose of study treatment.
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 28 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative serum or urine pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patients of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patient must have a negative urine pregnancy test within 5 days of study entry
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patients that are of childbearing age must have a negative pregnancy test at screening and agree on using contraception during the duration of the study
Pregnant and/or breastfeeding: patient must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of initiation of treatment
Pregnant or breastfeeding patients; women of childbearing potential must have a documented negative pregnancy test a maximum of 7 days before start of treatment
Pregnant and/or breastfeeding; premenopausal women must have a negative serum or urine pregnancy test within 14 days of study entry
Patient must not be pregnant and/or breastfeeding; patient must have a negative serum pregnancy test within 14 days of study entry
Pregnant or breastfeeding; a negative pregnancy test is required within 14 days of randomization for all women of childbearing potential
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding women; women of childbearing potential must have a negative serum pregnancy test within 14 days of study entry
Patient must not be pregnant and/or breastfeeding; patient must have a negative urine pregnancy test within seven days of study entry
Pregnant and/or breastfeeding; patient must have a negative serum or urine pregnancy test within 72 hours of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 7 days of study entry
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; patient must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; women of childbearing potential must have a negative pregnancy test within 14 days of study entry
Pregnant and/or breastfeeding; female patients must have a negative urine pregnancy test within 14 days of study entry
